-
-
New reports about proton pump inhibitors and the effects of gastric suppression, pioglitazone vs vitamin E for non-alcoholic steatohepatitis, metformin and vitamin B12 deficiency, and FDA Actions
-
The optimal timing of cardiac catheterization for patients suffering non-ST segment elevation myocardial infarction (nonSTEMI) remains a subject of debate.
-
The use of angiotensin converting enzyme (ACE) inhibitors in all acute myocardial infarction (MI) patients is controversial.
-
Little is known about the long-term prognosis of the no-reflow phenomenon after percutaneous intervention (PCI) for acute ST elevation myocardial infarction (STEMI).
-
Dronedarone is an antiarrhythmic drug with structural and electrophysiologic similarities to amiodarone that was released in 2009. Dronedarone's structure includes a benzofuranyl ring but, unlike amiodarone, the ring is not iodinated.
-
Strive to keep your practice up-to-date in 2010 with the publication of the U.S. Medical Eligibility Criteria for Contraceptive Use.
-
Clinicians face challenges when it comes to detecting ovarian cancer: 70% of women with ovarian cancer are diagnosed with advanced disease.
-
Research indicates that women are at risk for heightened HIV infection during pregnancy, but what about their partners?
-
For 50 years, women have had a reliable form of birth control in the form of the combined oral contraceptive pill. What has emerged in the same time period for men?
